A recent report published by Infinium Global Research on the atopic dermatitis drugs market provides an in-depth analysis of segments and sub-segments in global as well as regional atopic dermatitis drugs market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional atopic dermatitis drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global atopic dermatitis drugs market. According to the report the global atopic dermatitis drugs market is projected to grow at a CAGR of 3.5% over the forecast period of 2018-2024.
A disease without a known cause that is caused by both genetic as well as environmental factors is considered as idiopathic or Atopic dermatitis (AD). A skin disorder in which the skin becomes dry, itchy and inflamed this type of disorder is known as Atopic dermatitis (AD). Scratching of the skin leads to redness, scaling, cracking, weeping, swelling, and crusting. This condition is common in infants and children, even adult population is also affected by this disorder. People living in a dry climate are more likely to get affected. Generally, people with AD develop asthma and hay fever.
The growing occurrence of food allergies intensifying atopic dermatitis is likely to drive the growth of this market. Moreover, the growing risk of intense atopic dermatitis in infancy is related to food sensitization, which is commonly related to food allergy. Food items such as cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish cause such allergies. The monoclonal antibody named dupilumab, which is developed by sanofi and regeneron pharmaceuticals, Inc., for treating atopic diseases is expected to drive the growth of atopic dermatitis treatment market. Side effects related to drugs used in the treatment of AD are likely to hamper the growth of the market. The market offers opportunities for companies engaged in developing novel systemic therapies as there is a considerable need for medications with enhanced safety and efficacy profiles.
The report on the global atopic dermatitis drugs market covers segments such as the route of administration. On the basis of the route of administration the global atopic dermatitis drugs market is categorized into tropical ROA, injectable ROA, and oral ROA.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and the Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a healthy CAGR over the period of 2018-2024.
The report provides profiles of the companies in the global atopic dermatitis drugs market such as Mylan, LEO Pharma, Bayer HealthCare, Encore Dermatology, Novartis AG, Valent Pharmaceutical Inc., Astellas Pharma Inc., Meda AB, Valeant, and Others.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global atopic dermatitis drugs market. Moreover, the IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of atopic dermatitis drugs market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the atopic dermatitis drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the atopic dermatitis drugs market to understand the present and future trends in this market and formulate their strategies accordingly.